I am a Senior Medical Lead in the focus area of Cardiovascular, Renal and Metabolism at AstraZeneca Gothenburg. In short, I work to get our new diabetes treatments approved worldwide. This involves, among other things, conducting clinical trials, presenting data for medical authorities and publishing trial results in various medical journals.


I started at AstraZeneca's R&D site in Lund at the end of 2009 as a Global Safety Physician. When the site in Lund was closed and certain operations were relocated to AstraZeneca in Gothenburg, I chose to also move to be able to continue my work. 

 

I very much like my work, so we decided to move the whole family to Gothenburg. For me, it was an opportunity to extend my work in a field I am really passionate about; Cardiovascular, Renal and Metabolism (CVRM)

Ella Ekholm Vice President RIA Innovative Medicines, Cambridge, UK

At Global Medicines Development (GMD) in Gothenburg, medicines are developed from idea to market approval. Over 500 people work at GMD, and a significant number of them are involved in the research on diabetes. After three years at AstraZeneca´s Patient Safety department, I began working as a study physician at GMD, and later became Senior Medical Lead there.

I am a double specialist in internal medicine and endocrinology, and came to AstraZeneca from Malmö University Hospital, where I conducted clinical work within internal medicine and endocrinology. I received my Ph.D. for preclinical diabetes research from Uppsala University, and I am an Associate Professor in endocrinology at Lund University. I also hold a degree in Pharmaceutical Medicine (ECPM) from the University of Basel. 

 

I really enjoy the diversity in my work here. If you are interested in diabetes research, GMD in Gothenburg is one of the most interesting places to be right now.

Ella Ekholm Vice President RIA Innovative Medicines, Cambridge, UK